Is standby therapy for Covid-19 a practical option for travellers?

Lin H ChenBradley A Connor

Published in: Journal of travel medicine (2022)

International travel has resumed while the risk of SARS-CoV-2 persists, leading to consideration of medications that can treat or prevent Covid-19 when travellers become ill abroad. Nirmatrelvir-ritonavir, molnupiravir, and tixagevimab-cilgavimab are available under Emergency Use Authorization or conditional approval. We discuss the potential application of these medications to protect travellers.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
emergency department
public health
healthcare
risk assessment
antiretroviral therapy
human health
infectious diseases